The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Juan C. Diaz, MD, explained why conduction pacing may be the way of the future.

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

The FDA has labeled this as a Class I recall, which means using these devices can lead to significant injuries, including death.

Findings from the SOLVE-CRT study were presented to attendees at Heart Rhythm 2023. "Our results showed the study was safe, effective and feasible," Singh said. 

"The goal is to treat patients with life-threatening VT in a safer, faster and better way," one researcher explained.

These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 

Heart Rhythm 2023 in New Orleans brought together EP experts from all over the world. Scroll through a large selection of photos from the big event. 

The patient's leg remains disfigured years after the incident. 

The device, designed with improved filtration and stability in mind, is now being investigated as part of a new pilot study.